ExeVir Bio BV announces its participation in the 8th Annual Healthtech Investment Forum organized by SACHS Associates taking place virtually 5th-6th October 2021.
Torsten Mummenbrauer, Chief Executive Officer of ExeVir will be speaking on a panel discussion titled “Advances in Covid Therapeutics” taking place at 11.00 CET on Wednesday 6th October 2021 and chaired by Max Herrmann, Managing Director, Stifel Financial Corp.
